Description and impact of a community pharmacy-based Collaborative Practice Agreement
- 8 December 2025
- journal article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 66 (1) , 102998
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- ASHP Statement on the Community Pharmacist’s Role in the Care ContinuumAmerican Journal of Health-System Pharmacy, 2024
- Inhaler Adherence in COPD: A Crucial Step Towards the CorrectInternational Journal of Chronic Obstructive Pulmonary Disease, 2023
- Community pharmacist-led interventions for patients with type 2 diabetes in low-income and middle-income countries: A scoping reviewResearch in Social and Administrative Pharmacy, 2023
- Appropriate inhaler use in children with asthma: barriers and opportunities through the lens of the socio-ecological modelJournal of Asthma, 2022
- Implementation of a pharmacist-led hormonal contraceptive prescribing service in a campus community pharmacy in Indiana, United StatesContraception, 2022
- Analysis of prior authorization success and timeliness at a community-based specialty care pharmacyJournal of the American Pharmacists Association, 2021
- Evaluating the impact of influenza and streptococcus point-of-care testing and collaborative practice prescribing in a community pharmacy settingJournal of the American Pharmacists Association, 2020
- Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public HealthJournal of the American Pharmacists Association, 2020
- Pharmacy communications with physician offices to clarify prescriptionsJournal of the American Pharmacists Association, 2017
- The Impact of Clinical Pharmacists on Drug‐Related Problems and Clinical OutcomesBasic & Clinical Pharmacology & Toxicology, 2008